Orphan Vaccine Centers Could Produce Bioterror Products, NRC Report Says
Government-owned, contractor-operated facilities for orphan vaccines could facilitate mass manufacture of counterterrorism agents, the National Research Council suggested in a June 25 report
You may also be interested in...
Bioterrorism product research tax credits would be expanded to include companies with tax liability, such as larger biotech and pharma firms, under reworked legislation being developed by Sen. Joseph Lieberman (D-Conn.)
A national vaccine facility would not solve near-term supply problems, Centers for Disease Control & Prevention National Immunization Program Director Walter Orenstein, MD, suggested
The Biotechnology Industry Organization's indemnification proposal would require the government to defend against claims arising from potential adverse effects of bioterrorism vaccines